In an interview with RE$EARCH MONEY, Molly Shoichet discusses her new biotech startup, her experience as Ontario’s chief scientist, and her views on innovation in Canada.
Person: Dr Molly Shoichet
Cogent, timely science advice is a hallmark of advanced, knowledge-based nations but as recent Canadian events have demonstrated, that capacity can often be weakened or even taken away as political winds shift and governments change.
Shortly after naming a new Cabinet lacking a science or innovation minster, Ontario’s Progressive Conservative premier Doug Ford has reportedly fired the province’s first chief scientist, Dr Molly Shoichet.
The newly elected Ontario Progressive Conservative Party has eliminated research and innovation as a separate ministry as it unveiled its slimmed-down 21-person Cabinet.
Last fall, Ontario named its first chief scientist after a nearly year-long search, selecting Dr Molly Shoichet, a biomedical scientist in Univ of Toronto. RE$EARCH MONEY spoke with her last month to learn more about what she and her team will be working on.
After a months-long public search, Ontario has announced the appointment of Dr Molly Shoichet as its first chief scientist who will advise the provincial premier on science and innovation policy based on scientific evidence.
Ontario names Dr Molly Shoichet as its first chief scientist who will advise Premiere Kathleen Wynne on science and innovation policy based on scientific evidence.
The Canada Council for the Arts has announced the winners of the 2017 Killam Prizes, which celebrate world class excellence in the arts and sciences. This year’s five winners will each receive $100,000 at a May 30th awards ceremony at the Governor General’s residence in Ottawa on May 30. This year’s winners are: Dr John…
Dr Molly Shoichet has been awarded the 2015 L’Oreal-UNESCO For Women in Science Award — one of five awarded globally for achievement in the physical sciences. Shoichet is a Tier 1 Canada Research Chair in Tissue Engineering and professor of chemical engineering and applied chemistry, chemistry and biomaterials and biomedical engineering at the Univ of…
Francois Legault has been appointed board chairman of Montreal-based Verlyx Pharma Inc (formerly Oncozyme Pharma), a privately held biotechnology company focused on the treatment of liver disorders. Legault has a long career in the biotechnology industry. Positions include executive VP at BioChem Pharma prior to its acquisition by Shire Pharmaceuticals, and president, COO and co-founder…